ランキング価格はじめての方へ
  1. 米国企業
  2. TELA Bio, Inc.

TELA Bio, Inc.TELA

時価総額
$6563万
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日
Net loss---33-44
Depreciation0000
Paid-in-Kind Interest1111
Noncash loss on extinguishment of debt---1
Amortization of intangible assets0001
Net changes in operating lease ROU assets and liabilities---0
Inventory Write-down2112
Stock-based compensation expense0244
Loss on disposal of fixed assets---0-
Accounts receivable, net2-022
Inventory2156
Prepaid expenses and other assets2-01-1
Accounts payable-1-22-1
Accrued expenses and other current and long-term liabilities-0232
Foreign currency remeasurement loss-0-0-0
Net cash used in operating activities-26-24-30-41
Proceeds from the sale and maturity of short-term investments-9--
Payment for intangible asset3--1
Purchase of property and equipment0011
Net cash (used in) provided by investing activities-129-1-2
Proceeds from Issuance of Common Stock-0-34
Proceeds from issuance of long-term debt---40
Repayment of long-term debt---30
Payment of debt financing costs---3
Payment of initial public offering costs-1--
Proceeds from Stock Options Exercised0010
Payment of withholding taxes related to stock-based compensation to employees---0
Proceeds from Stock Plans---0
Net cash provided by financing activities6644141
Effect of exchange rate on cash and cash equivalents--0-0
Net (decrease) increase in cash and cash equivalents2829-30-2
Cash paid during the period for interest3333
Capital Expenditures Incurred but Not yet Paid-000
Stock Issued000-
Liability-classified stock-based compensation in accrued expenses and other current liabilities-0--
Reclassification Of Liability Classified Stock Based Compensation To Equity Classified--0-
Operating lease ROU asset exchanged for operating lease liabilities---1
Tenant Improvements and Deferred Rent Exchanged For Operating lease Liabilities---0
Operating lease liabilities assumed for operating lease ROU assets----2